Friday 6 November 2026 Export KYMR’s income statement to Excel — free account

Kymera Therapeutics, Inc.

Kymera Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $39.2 million, down 16.7% from fiscal 2024.

Revenue: +466.4%
EPS: −40.3%
Free cash flow: −186.6%
Total debt: −66.6%

Quarter to September 2026, against a year earlier

Insider buying

132.01 3.89 +3.04%

Follow KYMR

Alert me

Market cap: $10.9B
P/E: 0.0×
Fwd P/E: −31.6×
Dividend yield: —
F-score: 4/9
Altman Z: 23.22
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Valuation Filings

Kymera Therapeutics, Inc. (KYMR) P/E ratio

Alert me on P/E ratio

Kymera Therapeutics, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 0.0× (November 2026) — the current reading is the highest in ten years.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/KYMR/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Kymera Therapeutics, Inc. P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/KYMR/metrics/pe-ratio">Kymera Therapeutics, Inc. (KYMR) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	0.0×	—
FY2024	0.0×	—
FY2023	0.0×	—
FY2022	0.0×	—
FY2021	0.0×	—
FY2020	0.0×	—
FY2019	0.0×	—

Period	P/E ratio	Change
Jun 2026	0.0×	—
Mar 2026	0.0×	—
Dec 2025	0.0×	—
Sep 2025	0.0×	—
23 more quarters	Free account

Against its own ten years

Low 0.0× High 0.0×

Ten-year median 0.0×

Current reading's percentile 100

Company	P/E ratio
TWST Twist Bioscience Corporation compare	n/m
IBRX ImmunityBio, Inc. compare	n/m
KYMR Kymera Therapeutics, Inc.	n/m
BMRN BioMarin Pharmaceutical Inc. compare	n/m
SMMT Summit Therapeutics PLC compare	n/m
PCVX Vaxcyte, Inc. compare	n/m
TGTX TG Therapeutics, Inc. compare	19.1×
TECH Bio-Techne Corp compare	62.2×
CAI Caris Life Sciences,�Inc. compare	77.7×
Biotechnology industry median	10.3×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Kymera Therapeutics, Inc. (KYMR) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on KYMR

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on KYMR

Stockrow Weekly